MS, Diabetes Groups Form Partnership With Italian Biotech In Drug-Discovery Effort
This article was originally published in The Pink Sheet Daily
Executive Summary
Axxam will seek to discover ion channel modulators that show potential efficacy in type 1 diabetes and/or multiple sclerosis.